Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing exercise responses in bronchiectasis patients and healthy individuals

Official title: Comparison of Cardiopulmonary Responses to 6-Minute Stepper Test Between Individuals With Bronchiectasis and Healthy Controls

Run by Hacettepe University · NCT06631261 · Data updated 2026-11-12

This study tests how people with bronchiectasis respond to exercise compared to healthy individuals to understand their exercise limitations better.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 18, 2024
Main results expectedJanuary 18, 2027
Study endsJanuary 18, 2027
Registry record updatedJune 25, 2026
Trial IDNCT06631261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with clinically stable bronchiectasis who can cooperate with the testing procedures.

Probably not a fit

Patients experiencing acute exacerbations or those with cardiovascular, orthopedic, or neurological issues that may affect test performance are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the cardiopulmonary responses of individuals with bronchiectasis during a 6-minute stepper test (6MST) and compare these responses to those of age and sex-matched healthy controls. The study will evaluate exercise capacity and physical activity levels, utilizing the 6MST and the 1-minute sit-to-stand test (1STS) to gather data. By investigating these parameters, the study seeks to provide insights into the exercise limitations faced by bronchiectasis patients compared to healthy individuals.

Why it matters

Potential benefit: If successful, this study could enhance understanding of exercise capacity in bronchiectasis, potentially leading to improved management strategies for patients.

How similar studies have gone: While there is limited information on the specific tests being used, similar studies have shown that assessing exercise capacity in chronic lung diseases can yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Bronchiectasis group - Inclusion criteria for the study:

* Being 18 years of age and older,
* Having a clinically stable bronchiectasis,
* To cooperate with the tests to be performed,
* Not having a cardiovascular disease, orthopedic or neurological problem that may affect the tests,
* Being willing to participate in the study.

Bronchiectasis group - Exclusion criteria:

* Being in an acute exacerbation period,
* Having a cardiovascular, orthopedic or neurological problem that may affect the tests,
* Not being willing to participate in the study.

Control group - Inclusion criteria for the study:

* Being 18 years of age and older,
* To cooperate with the tests to be performed,
* Not having a cardiovascular, orthopedic or neurological problem that may affect the tests,
* Being willing to participate in the study.

Control group - Exclusion criteria:

\- Individuals with any known internal disease and those who do not volunteer to participate in the study will not be included in the study.

Where it's running

  • Hacettepe University Faculty of Physical Therapy and Rehabilitation
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.